Evidence map›Paper›PMID 28490571›Full record

ArticleBlood2017

Evaluating a CLL susceptibility variant in

Nicholas B Blackburn, James R Marthick, Annette Banks, Jac C Charlesworth, Katherine A Marsden, Ray M Lowenthal, John Blangero, Joanne L Dickinson

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Inhibitory effect ofAnnals of translational medicine · 2022
    Article
  2. Article
  3. Article
  4. Review
  5. Analysis ofBlood · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Nicholas B BlackburnSouth Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX.ORCID 0000-0002-9774-1539
James R MarthickMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; and.
Annette BanksMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; and.
Jac C CharlesworthMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; and.ORCID 0000-0001-6201-3518
Katherine A MarsdenRoyal Hobart Hospital, Hobart, TAS, Australia.
Ray M LowenthalMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; and.
John BlangeroSouth Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX.ORCID 0000-0001-6250-5723
Joanne L DickinsonMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; and.ORCID 0000-0003-4621-1703
University of Tasmania · AURoyal Hobart Hospital · AUThe University of Texas Rio Grande Valley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Polymorphism, Single NucleotideCohort StudiesGenetic Predisposition to DiseaseHematologic NeoplasmsHumansLeukemia, Lymphocytic, Chronic, B-CellLymphocyte Function-Associated Antigen-1Neoplastic Syndromes, HereditarySequence Analysis, DNATasmaniaLymphocyte Function-Associated Antigen-1

Identifiers

PMID28490571
PMCPMC5813724
OpenAlexW2612497493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.